Listed

Alto Neuroscience, Inc.

ANRONYSECIK 1999480HealthcareFiscal year ends Dec 31

Reports and events: 46 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Alto Neuroscience, Inc., Reports and events
FiledFormWhat it isAccession number
2026-08-2717:18 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001999480-26-000024
2026-08-1216:27 ET10-QQuarterly reportPeriod 2026-06-300001999480-26-000023
2026-08-1216:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-26-000022
2026-07-1406:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-26-083274
2026-07-1307:39 ET8-K2.02 Results of operations; 8.01 Other events0001104659-26-082875
2026-05-2808:18 ET8-K5.02 Departure or appointment of officers or directors0001999480-26-000016
2026-05-1316:21 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001999480-26-000014
2026-05-1307:30 ET10-QQuarterly reportPeriod 2026-03-310001999480-26-000012
2026-05-1307:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-26-000011
2026-04-0116:55 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-038593
2026-03-2616:06 ETDEF 14AProxy statementPeriod 2026-05-120001104659-26-035180
2026-03-1607:08 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-027953
2026-03-1606:07 ET10-KAnnual reportPeriod 2025-12-310001999480-26-000002
2026-03-1606:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-26-000001
2025-11-1208:32 ET10-QQuarterly reportPeriod 2025-09-300001999480-25-000090
2025-11-1208:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-25-000089
2025-10-2016:01 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-25-100801
2025-08-1316:33 ET10-QQuarterly reportPeriod 2025-06-300001999480-25-000076
2025-08-1316:11 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001999480-25-000075
2025-07-0817:18 ET8-K5.02 Departure or appointment of officers or directors0001999480-25-000061
2025-06-2607:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001999480-25-000053
2025-06-0306:34 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001999480-25-000048
2025-05-1416:32 ET10-QQuarterly reportPeriod 2025-03-310001999480-25-000037
2025-05-1416:15 ET8-K2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001999480-25-000035
2025-04-0116:17 ETDEF 14AProxy statementPeriod 2025-05-130001193125-25-070446
2025-03-2016:36 ET10-KAnnual reportPeriod 2024-12-310001999480-25-000025
2025-03-2016:32 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001999480-25-000024
2025-02-1208:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-25-024814
2025-02-0316:39 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-25-019318
2025-01-1607:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-25-007383
2024-11-1216:24 ET10-QQuarterly reportPeriod 2024-09-300001999480-24-000042
2024-11-1216:20 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-24-000040
2024-10-2216:35 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-24-241092
2024-08-1316:36 ET10-QQuarterly reportPeriod 2024-06-300001999480-24-000035
2024-08-1316:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-24-000033
2024-07-2916:19 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001999480-24-000025
2024-05-2108:29 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-143369
2024-05-1416:32 ET10-QQuarterly reportPeriod 2024-03-310001999480-24-000022
2024-05-1416:25 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-24-000020
2024-03-2116:26 ET10-KAnnual reportPeriod 2023-12-310001999480-24-000010
2024-03-2116:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001999480-24-000008
2024-03-1108:20 ET8-K5.02 Departure or appointment of officers or directors0001193125-24-064372
2024-02-0616:07 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-24-025266
2024-01-2910:35 ETS-1/ARegistration statement, amended0001193125-24-017660
2024-01-2907:36 ETS-1/ARegistration statement, amended0001193125-24-017403
2024-01-1216:50 ETS-1Registration statement0001193125-24-007592

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 11:02 ET. Listed shows no prices and gives no investment advice.